Comments to FDA: Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an OTC Monograph Share page: Docket Number: FDA-2018-D-1456 Download Document Issues: OTC Medicines Sunscreen Other Issues Research Related Posts Articles Polibrief: Post-Consumer Recycled Content Jul 9, 2024 Press Releases and Statements CHPA Statement on U.S. Supreme Court Overturning the Chevron Standard Jun 28, 2024 Press Releases and Statements CHPA Welcomes New Board Members at June Meeting Jun 14, 2024